Brought to you by 
Zhifei Biological completes RMB1.4bn IPO on Shenzhen Exchange
28 Oct 2010
Executive Summary
Chinese vaccines company Chongqing Zhifei Biological Products Co. Ltd. (Zhifei) has completed a 40mm-share IPO priced at RMB37.98 ($5.71), netting RMB1.43bn ($215mm). The company listed on the Shenzhen Exchange's Growth Enterprise Market (GEM) index.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zhifei Biological completes RMB1.4bn IPO on Shenzhen Exchange
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice